APOA2 Protein (AA 19-100) (His tag)

N° du produit ABIN6809938

Détail du produit

Antigène: APOA2 (Apolipoprotein A-II (APOA2))

Type de proteíne: Recombinant

Attributs du protein: AA 19-100

Origine: Humain

Source: Escherichia coli (E. coli)

Purification/Conjugué: Cette APOA2 protéine est marqué à la His tag.

Séquence: AA 19-100

Pureté: >90 % as determined by SDS-PAGE.

niveau d'endotoxine: Less than 1.0 EU per μg by the LAL method.

Information d'application

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Buffer: PBS, pH 7.4

Conseil sur la manipulation: Please avoid repeated freeze-thaw cycles.

Stock: -20 °C

Détail du antigène

Antigène: APOA2 (Apolipoprotein A-II (APOA2))

Autre désignation: Apolipoprotein A-II (APOA2 Produits)

Synonymes: Apo-AII Protein, ApoA-II Protein, apoAII Protein, Alp-2 Protein, ApoAII Protein, Apoa-2 Protein, Hdl-1 Protein, APOAII Protein, apoa2 Protein, apoA-II Protein, cb1032 Protein, wu:fb57h11 Protein, zgc:193613 Protein, apolipoprotein A2 Protein, apolipoprotein A-II Protein, APOA2 Protein, Apoa2 Protein, apoa2 Protein

Sujet: Apolipoprotein A-II(APO-A2) stabilize HDL (high density lipoprotein) structure by its association with lipids, and affect the HDL metabolism. It is produced by the liver and is involved in cholesteryl ester formation and cholesterol transport from tissues to the liver. Recent studies have established the interaction between APOA2 -256T>C polymorphism and dietary saturated fatty acids intake in relation to obesity on healthy individuals. Significant interaction between APOA2-saturated fatty acids intake and body mass index (BMI). The result of this study confirmed the interaction between APOA2 -256T>C polymorphism and SFAs intake with BMI in type 2 diabetic patients.

Poids moléculaire: 11.3 kDa

NCBI Accession: NP_001634

Pathways: Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism